1. Home
  2. PWM vs SNPX Comparison

PWM vs SNPX Comparison

Compare PWM & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PWM
  • SNPX
  • Stock Information
  • Founded
  • PWM 2018
  • SNPX 2012
  • Country
  • PWM Hong Kong
  • SNPX United States
  • Employees
  • PWM N/A
  • SNPX N/A
  • Industry
  • PWM
  • SNPX Medicinal Chemicals and Botanical Products
  • Sector
  • PWM
  • SNPX Health Care
  • Exchange
  • PWM Nasdaq
  • SNPX Nasdaq
  • Market Cap
  • PWM N/A
  • SNPX 3.1M
  • IPO Year
  • PWM 2023
  • SNPX N/A
  • Fundamental
  • Price
  • PWM $0.39
  • SNPX $2.40
  • Analyst Decision
  • PWM
  • SNPX Strong Buy
  • Analyst Count
  • PWM 0
  • SNPX 1
  • Target Price
  • PWM N/A
  • SNPX $14.00
  • AVG Volume (30 Days)
  • PWM 291.3K
  • SNPX 5.6K
  • Earning Date
  • PWM 05-13-2025
  • SNPX 05-19-2025
  • Dividend Yield
  • PWM N/A
  • SNPX N/A
  • EPS Growth
  • PWM N/A
  • SNPX N/A
  • EPS
  • PWM N/A
  • SNPX N/A
  • Revenue
  • PWM $639,912.00
  • SNPX N/A
  • Revenue This Year
  • PWM N/A
  • SNPX N/A
  • Revenue Next Year
  • PWM N/A
  • SNPX N/A
  • P/E Ratio
  • PWM N/A
  • SNPX N/A
  • Revenue Growth
  • PWM N/A
  • SNPX N/A
  • 52 Week Low
  • PWM $0.31
  • SNPX $1.84
  • 52 Week High
  • PWM $2.70
  • SNPX $5.09
  • Technical
  • Relative Strength Index (RSI)
  • PWM 47.30
  • SNPX 51.45
  • Support Level
  • PWM $0.37
  • SNPX $2.34
  • Resistance Level
  • PWM $0.48
  • SNPX $2.58
  • Average True Range (ATR)
  • PWM 0.05
  • SNPX 0.11
  • MACD
  • PWM 0.02
  • SNPX 0.03
  • Stochastic Oscillator
  • PWM 48.82
  • SNPX 65.91

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

Share on Social Networks: